品牌咨询
联系方式
公司地址
苏州工业园区生物纳米园A4#216
联系电话
4000-520-616 / 18915418616
传真号码
0512-67156496
电子邮箱
info@ebiomall.com
公司网址
https://www.ebiomall.com

Hycult Biotech/CD163, Rat, mAb ED2 | Hycult Biotech/HM3025

价格
¥7820.00
货号:HM3025
浏览量:65
品牌:Hycult Biotech
服务
全国联保
正品保证
正规发票
签订合同
商品描述
Monoclonal antibody ED2 reacts with rat CD163 cell surface glycoprotein, a 175 kDa molecule also known as ED2. CD163 is expressed by approximately 50% of peritoneal macrophages, a subset of splenic macrophages, and by macrophages in most other tissues. However, it is not expressed by monocytes, alveolar macrophages or microglial cells. Macrophage scavenger receptor CD163 also known as hemoglobin scavenger receptor (HbSR) is a member of the scavenger receptor cysteine-rich family (SRCR). Scavenger receptors have been studied primarily for their ability to bind and internalize modified lipoproteins. They have been found to be involved in the development of atherosclerosis. Scavenger receptors also function as pattern recognition receptors for a wide variety of pathogens indicating a potential role in host defence.CD163 is involved in the endocytosis of hemoglobin:haptoglobin complexes and is able to counter oxidative tissue damage induced by hemoglobin after hemolysis. Recent results identify new anti-inflammatory and cytoprotective effector pathways in monocytes/macrophages related to hemoglobin scavenging and metabolism, which may be relevant for atheroprotection and wound healing.
Hycult Biotech当您在研究项目中寻找中小企业合作伙伴时,Hycult Biotech是您的首选合作伙伴。凭借我们的背景和专业知识,我们可以为您的项目增值:从成为财团的负责人到成为科学项目的推动力,我们都有在科学项目中扮演不同角色的经验。由于我们遍布全球的广泛网络,我们可以在寻找研究项目的合作伙伴方面发挥核心作用。我们可以协助撰写建议书或建立财团。获得科学资助的我们的研究活动示例:生物标志物测定法的发展抗体的表征。从概念到最终产品。Hycult Biotech代表什么从1994年开始创建分析,抗体和蛋白质。根据ISO13485指南开发和生产(IVD)套件。关于复杂基质中蛋白质难以测量的广泛知识。制药和生物技术行业的伴侣诊断合作伙伴。 Hycult Biotech目前参与以下研究项目OPZuid:Zuid-Nederland行动纲领Hycult Biotech利用“ OP Zuid”资金,目前正在研究开发针对类风湿性关节炎和骨关节炎的创新诊断测试的可能性。使用该测试可以更好地监视患者及其疾病活动,严重程度和治疗反应。更好的诊断结合个性化治疗将大大改善这些患者的生活质量。相关:缓解慢性自身免疫性疾病的预防RELENT项目提供了探索新的研究领域并加深其对自身免疫和炎症领域的见解的机会。Hycult Biotech在该主题非常适合的慢性炎性疾病领域中不断扩展产品。寻找与RA,IBD和AASV相关的新型靶蛋白将为进一步进入诊断领域提供机会。 Hycult Biotech已成功参与以下研究项目-DIREKT:解除血管内固有免疫反应,改善慢性肾脏病的治疗方式-PREDICCt:糖尿病和与糖尿病相关的心血管并发症的预测和早期诊断的生物标志物-TranSVIR:转化为血管炎症和修复的科学-指示:慢性自身免疫的传染性诱因 有关科学赠款和合作的更多信息,请参见以下传单: